What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Heart failure
- Cardiology
His scientific interests lie mostly in Heart failure, Internal medicine, Cardiology, Ejection fraction and Intensive care medicine.
His Heart failure research integrates issues from Clinical trial, Surgery, Blood pressure, Serelaxin and Placebo.
Internal medicine is often connected to Endocrinology in his work.
His study in Cardiology is interdisciplinary in nature, drawing from both Renal function and Heart rate.
His Ejection fraction study integrates concerns from other disciplines, such as Pulmonary wedge pressure, Prospective cohort study and Cohort.
The Intensive care medicine study combines topics in areas such as Survival rate, Nesiritide and Myocardial infarction.
His most cited work include:
- Guidelines on the management of valvular heart disease The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (3367 citations)
- ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society (2438 citations)
- Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). (1544 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Heart failure, Internal medicine, Cardiology, Intensive care medicine and Ejection fraction.
His work deals with themes such as Clinical trial, Renal function, Blood pressure, Placebo and Hemodynamics, which intersect with Heart failure.
His research in Renal function intersects with topics in Creatinine and Rolofylline.
In his research, he undertakes multidisciplinary study on Internal medicine and In patient.
His Cardiology study combines topics in areas such as Serelaxin and Surgery.
Many of his studies involve connections with topics such as Randomized controlled trial and Intensive care medicine.
He most often published in these fields:
- Heart failure (71.35%)
- Internal medicine (68.80%)
- Cardiology (58.36%)
What were the highlights of his more recent work (between 2019-2021)?
- Heart failure (71.35%)
- Internal medicine (68.80%)
- Cardiology (58.36%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Heart failure, Internal medicine, Cardiology, Ejection fraction and In patient.
Marco Metra has researched Heart failure in several fields, including Diabetes mellitus, Clinical trial, Randomized controlled trial and Intensive care medicine.
Internal medicine is represented through his Hazard ratio, Cohort, Atrial fibrillation, Confidence interval and Incidence research.
His Atrial fibrillation research includes themes of Coronary artery disease and Concomitant.
Cardiology and Clinical endpoint are commonly linked in his work.
The study incorporates disciplines such as Omecamtiv mecarbil, Cardiac function curve, Blood pressure, Placebo and Empagliflozin in addition to Ejection fraction.
Between 2019 and 2021, his most popular works were:
- Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). (814 citations)
- Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy. (398 citations)
- Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors. (203 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Heart failure
- Cardiology
Marco Metra mainly focuses on Heart failure, Internal medicine, Cardiology, Ejection fraction and Severe acute respiratory syndrome coronavirus 2.
His study in Heart failure is interdisciplinary in nature, drawing from both Diabetes mellitus, Type 2 diabetes, Troponin, Adverse effect and Biomarker.
Marco Metra combines Internal medicine and In patient in his research.
His Cardiology research is multidisciplinary, incorporating perspectives in Etiology and Renal function.
His Renal function research includes elements of Creatinine, Tolerability, Serelaxin, Acute kidney injury and Cardiac resynchronization therapy.
Marco Metra has researched Ejection fraction in several fields, including Omecamtiv mecarbil, Canagliflozin, Placebo, Dapagliflozin and Empagliflozin.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
